ANIK logo

Anika Therapeutics (ANIK) Selling, General & Administrative Expenses

Annual SGA

$95.85 M
+$11.05 M+13.04%

December 31, 2023

Summary

Performance

1-Year Change

+13.04%

3-Year Change

+59.58%

5-Year Change

+179.14%

15-Year Change

+344.97%

ANIK SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

71.53%
ANIK annual SGA is higher than 71.53% of companies in Healthcare sector

High & Low

All-time High

$95.85 M
ANIK annual SGA is currently at an all-time high

3-Year Low

$74.10 M
ANIK annual SGA is currently +29.36% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ANIK previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 12, 2025
ANIK next annual earnings announcement is scheduled for Mar 12, 2025

OtherANIKexpensesmetrics:

Annual Total Expenses

$192.11 M
ANIK annual total expenses is $192.11 million

Annual Operating Expenses

$128.54 M
ANIK annual total operating expenses is $128.54 million

Annual Cost Of Goods Sold

$63.57 M
ANIK annual cost of goods sold is $63.57 million

Annual Interest Expense

-
ANIK annual interest expense value is unknown

Quarterly SGA

$19.11 M
-$694.00 K-3.50%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+9.21%

5-Year Change

+153.51%

ANIK Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

66.58%
ANIK quarterly SGA is higher than 66.58% of companies in Healthcare sector

High & Low

All-time High

$27.00 M
ANIK quarterly SGA is currently -29.20% below its historical high of $27.00 million

3-Year Low

$19.11 M
ANIK quarterly SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ANIK previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
ANIK next earnings announcement is scheduled for Mar 12, 2025

OtherANIKexpensesmetrics:

Quarterly Total Expenses

$63.67 M
ANIK quarterly total expenses is $63.67 million

Quarterly Operating Expenses

$26.36 M
ANIK quarterly total operating expenses is $26.36 million

Quarterly Cost Of Goods Sold

$37.31 M
ANIK quarterly cost of goods sold is $37.31 million

Quarterly Interest Expense

-
ANIK quarterly interest expense value is unknown

TTM SGA

$468.57 M
-$97.52 M-17.23%

September 30, 2024

Summary

Performance

3-Month Change

+480.06%

1-Year Change

+480.06%

3-Year Change

+580.64%

5-Year Change

+1240.69%

ANIK TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.26%
ANIK TTM SGA is higher than 89.26% of companies in Healthcare sector

High & Low

All-time High

$981.53 M
ANIK TTM SGA is currently -52.26% below its historical high of $981.53 million

3-Year Low

$468.57 M
ANIK TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ANIK previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
ANIK next earnings announcement is scheduled for Mar 12, 2025

OtherANIKexpensesmetrics:

Annual Total Expenses

$192.11 M
ANIK annual total expenses is $192.11 million

Annual Operating Expenses

$128.54 M
ANIK annual total operating expenses is $128.54 million

TTM Cost Of Goods Sold

$84.41 M
ANIK TTM cost of goods sold is $84.41 million

TTM Interest Expense

-
ANIK TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$95.85 M
ANIK annual SGA is $95.85 million

Annual Operating Expenses

$128.54 M
ANIK annual total operating expenses is $128.54 million

Annual Cost Of Goods Sold

$63.57 M
ANIK annual cost of goods sold is $63.57 million

ANIK Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+13.0%0.0%+480.1%
3 y3 years+59.6%+9.2%+580.6%
5 y5 years+179.1%+153.5%+1240.7%

ANIK Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+29.4%-29.2%at low-48.6%at low
5 y5-yearat high+174.2%-29.2%+56.2%-52.3%at low
alltimeall timeat high>+9999.0%-29.2%>+9999.0%-52.3%+894.8%

Anika Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$19.11 M(-3.5%)
$80.78 M(-6.6%)
Jun 2024
-
$19.81 M(-8.0%)
$86.50 M(-4.3%)
Mar 2024
-
$21.53 M(+5.9%)
$90.38 M(-5.7%)
Dec 2023
$95.85 M(+13.0%)
$20.34 M(-18.1%)
$95.85 M(-2.8%)
Sep 2023
-
$24.83 M(+4.8%)
$98.56 M(+3.7%)
Jun 2023
-
$23.69 M(-12.2%)
$95.01 M(+2.6%)
Mar 2023
-
$27.00 M(+17.1%)
$92.59 M(+9.2%)
Dec 2022
$84.79 M(+14.4%)
$23.05 M(+8.3%)
$84.79 M(+3.2%)
Sep 2022
-
$21.28 M(+0.0%)
$82.18 M(+4.8%)
Jun 2022
-
$21.27 M(+10.8%)
$78.40 M(+4.4%)
Mar 2022
-
$19.20 M(-6.0%)
$75.12 M(+1.4%)
Dec 2021
$74.10 M(+23.4%)
$20.43 M(+16.8%)
$74.10 M(+7.6%)
Sep 2021
-
$17.50 M(-2.7%)
$68.84 M(+2.4%)
Jun 2021
-
$17.99 M(-1.0%)
$67.25 M(+5.4%)
Mar 2021
-
$18.18 M(+19.7%)
$63.81 M(+6.2%)
Dec 2020
$60.06 M(+71.9%)
$15.18 M(-4.6%)
$60.06 M(+5.2%)
Sep 2020
-
$15.90 M(+9.3%)
$57.12 M(+17.2%)
Jun 2020
-
$14.55 M(+0.8%)
$48.76 M(+16.9%)
Mar 2020
-
$14.43 M(+17.9%)
$41.71 M(+19.3%)
Dec 2019
$34.95 M(+1.8%)
$12.24 M(+62.3%)
$34.95 M(+21.2%)
Sep 2019
-
$7.54 M(+0.5%)
$28.84 M(+6.8%)
Jun 2019
-
$7.50 M(-2.2%)
$27.00 M(+4.2%)
Mar 2019
-
$7.67 M(+25.2%)
$25.92 M(-24.5%)
Dec 2018
$34.34 M(+59.4%)
$6.13 M(+7.5%)
$34.34 M(-1.6%)
Sep 2018
-
$5.70 M(-11.2%)
$34.88 M(+2.6%)
Jun 2018
-
$6.42 M(-60.1%)
$34.01 M(+4.4%)
Mar 2018
-
$16.09 M(+140.9%)
$32.56 M(+51.2%)
Dec 2017
$21.54 M(+19.6%)
$6.68 M(+38.5%)
$21.54 M(+5.8%)
Sep 2017
-
$4.82 M(-3.0%)
$20.35 M(+2.7%)
Jun 2017
-
$4.97 M(-1.9%)
$19.81 M(+3.8%)
Mar 2017
-
$5.07 M(-7.7%)
$19.09 M(+6.0%)
Dec 2016
$18.01 M(+21.5%)
$5.49 M(+28.2%)
$18.01 M(+5.7%)
Sep 2016
-
$4.28 M(+0.6%)
$17.05 M(+6.0%)
Jun 2016
-
$4.25 M(+6.6%)
$16.08 M(+5.7%)
Mar 2016
-
$3.99 M(-11.8%)
$15.21 M(+2.6%)
Dec 2015
$14.82 M(-1.7%)
$4.52 M(+36.7%)
$14.82 M(+6.1%)
Sep 2015
-
$3.31 M(-2.3%)
$13.97 M(-5.0%)
Jun 2015
-
$3.39 M(-6.0%)
$14.71 M(-3.1%)
Mar 2015
-
$3.60 M(-1.8%)
$15.19 M(+0.8%)
Dec 2014
$15.07 M(+16.5%)
$3.67 M(-9.2%)
$15.07 M(+9.2%)
Sep 2014
-
$4.04 M(+4.6%)
$13.80 M(+6.6%)
Jun 2014
-
$3.87 M(+10.7%)
$12.95 M(+3.7%)
Mar 2014
-
$3.49 M(+45.5%)
$12.48 M(-3.5%)
Dec 2013
$12.94 M(-12.2%)
$2.40 M(-24.7%)
$12.94 M(-8.9%)
Sep 2013
-
$3.19 M(-6.2%)
$14.20 M(-2.8%)
Jun 2013
-
$3.40 M(-13.8%)
$14.62 M(-4.6%)
Mar 2013
-
$3.95 M(+7.6%)
$15.32 M(+4.0%)
Dec 2012
$14.73 M(-17.5%)
$3.67 M(+1.8%)
$14.73 M(-7.5%)
Sep 2012
-
$3.60 M(-12.3%)
$15.93 M(-6.5%)
Jun 2012
-
$4.11 M(+22.6%)
$17.04 M(-0.7%)
Mar 2012
-
$3.35 M(-31.2%)
$17.17 M(-3.9%)
Dec 2011
$17.86 M(+3.1%)
$4.87 M(+3.3%)
$17.86 M(+4.2%)
Sep 2011
-
$4.71 M(+11.3%)
$17.14 M(+4.9%)
Jun 2011
-
$4.23 M(+4.7%)
$16.34 M(-4.3%)
Mar 2011
-
$4.04 M(-2.6%)
$17.07 M(-1.4%)
Dec 2010
$17.32 M(+64.2%)
$4.15 M(+6.3%)
$17.32 M(+14.7%)
Sep 2010
-
$3.91 M(-21.3%)
$15.10 M(+7.6%)
Jun 2010
-
$4.97 M(+15.8%)
$14.03 M(+18.9%)
Mar 2010
-
$4.29 M(+122.0%)
$11.80 M(+11.9%)
Dec 2009
$10.55 M(-3.8%)
$1.93 M(-32.1%)
$10.55 M(-4.7%)
Sep 2009
-
$2.84 M(+3.9%)
$11.06 M(+2.6%)
Jun 2009
-
$2.74 M(-9.9%)
$10.79 M(-1.3%)
Mar 2009
-
$3.04 M(+23.9%)
$10.93 M(-0.3%)
Dec 2008
$10.97 M
$2.45 M(-4.6%)
$10.97 M(-3.8%)
DateAnnualQuarterlyTTM
Sep 2008
-
$2.57 M(-10.9%)
$11.40 M(+7.0%)
Jun 2008
-
$2.88 M(-6.1%)
$10.65 M(+12.3%)
Mar 2008
-
$3.07 M(+6.4%)
$9.49 M(+18.7%)
Dec 2007
$8.00 M(+19.7%)
$2.88 M(+58.4%)
$8.00 M(+21.7%)
Sep 2007
-
$1.82 M(+6.1%)
$6.57 M(+5.9%)
Jun 2007
-
$1.72 M(+9.0%)
$6.20 M(-4.0%)
Mar 2007
-
$1.58 M(+7.9%)
$6.46 M(-3.2%)
Dec 2006
$6.68 M(+23.5%)
$1.46 M(+0.4%)
$6.68 M(+3.3%)
Sep 2006
-
$1.45 M(-26.5%)
$6.47 M(+0.9%)
Jun 2006
-
$1.98 M(+10.5%)
$6.41 M(+8.5%)
Mar 2006
-
$1.79 M(+43.3%)
$5.91 M(+9.2%)
Dec 2005
$5.41 M(-10.5%)
$1.25 M(-10.4%)
$5.41 M(-10.3%)
Sep 2005
-
$1.39 M(-5.6%)
$6.03 M(-1.0%)
Jun 2005
-
$1.48 M(+14.2%)
$6.09 M(+1.1%)
Mar 2005
-
$1.29 M(-30.9%)
$6.03 M(-0.3%)
Dec 2004
$6.04 M(+43.5%)
$1.87 M(+28.3%)
$6.04 M(+11.1%)
Sep 2004
-
$1.46 M(+3.6%)
$5.44 M(+11.8%)
Jun 2004
-
$1.41 M(+7.6%)
$4.86 M(+10.5%)
Mar 2004
-
$1.31 M(+3.5%)
$4.40 M(+4.6%)
Dec 2003
$4.21 M(-4.9%)
$1.26 M(+42.8%)
$4.21 M(+5.2%)
Sep 2003
-
$885.00 K(-6.3%)
$4.00 M(-0.4%)
Jun 2003
-
$945.00 K(-15.2%)
$4.02 M(-9.9%)
Mar 2003
-
$1.11 M(+5.5%)
$4.46 M(+0.8%)
Dec 2002
$4.42 M(-28.8%)
$1.06 M(+17.4%)
$4.43 M(-15.5%)
Sep 2002
-
$900.00 K(-35.2%)
$5.23 M(-3.7%)
Jun 2002
-
$1.39 M(+28.7%)
$5.43 M(-8.0%)
Mar 2002
-
$1.08 M(-42.1%)
$5.90 M(-5.9%)
Dec 2001
$6.21 M(+48.4%)
$1.87 M(+69.6%)
$6.28 M(+13.7%)
Sep 2001
-
$1.10 M(-40.8%)
$5.52 M(+0.1%)
Jun 2001
-
$1.86 M(+27.9%)
$5.51 M(+19.0%)
Mar 2001
-
$1.45 M(+31.2%)
$4.63 M(+10.8%)
Dec 2000
$4.19 M(+38.2%)
$1.11 M(+1.3%)
$4.18 M(+10.0%)
Sep 2000
-
$1.09 M(+11.9%)
$3.80 M(+11.6%)
Jun 2000
-
$977.20 K(-2.2%)
$3.41 M(+5.5%)
Mar 2000
-
$999.50 K(+37.0%)
$3.23 M(+6.6%)
Dec 1999
$3.03 M(+12.2%)
$729.40 K(+4.2%)
$3.03 M(+4.5%)
Sep 1999
-
$700.00 K(-12.5%)
$2.90 M(-6.5%)
Jun 1999
-
$800.00 K(0.0%)
$3.10 M(+3.3%)
Mar 1999
-
$800.00 K(+33.3%)
$3.00 M(+11.1%)
Dec 1998
$2.70 M(+28.6%)
$600.00 K(-33.3%)
$2.70 M(-6.9%)
Sep 1998
-
$900.00 K(+28.6%)
$2.90 M(+20.8%)
Jun 1998
-
$700.00 K(+40.0%)
$2.40 M(+14.3%)
Mar 1998
-
$500.00 K(-37.5%)
$2.10 M(+5.0%)
Dec 1997
$2.10 M(-19.2%)
$800.00 K(+100.0%)
$2.00 M(+17.6%)
Sep 1997
-
$400.00 K(0.0%)
$1.70 M(-5.6%)
Jun 1997
-
$400.00 K(0.0%)
$1.80 M(0.0%)
Mar 1997
-
$400.00 K(-20.0%)
$1.80 M(0.0%)
Dec 1996
$2.60 M(+73.3%)
-
-
Nov 1996
-
$500.00 K(0.0%)
$1.80 M(+12.5%)
Aug 1996
-
$500.00 K(+25.0%)
$1.60 M(+23.1%)
Aug 1996
$1.50 M(+66.7%)
-
-
May 1996
-
$400.00 K(0.0%)
$1.30 M(+18.2%)
Feb 1996
-
$400.00 K(+33.3%)
$1.10 M(+22.2%)
Nov 1995
-
$300.00 K(+50.0%)
$900.00 K(+12.5%)
Aug 1995
$900.00 K(+28.6%)
$200.00 K(0.0%)
$800.00 K(0.0%)
May 1995
-
$200.00 K(0.0%)
$800.00 K(0.0%)
Feb 1995
-
$200.00 K(0.0%)
$800.00 K(0.0%)
Nov 1994
-
$200.00 K(0.0%)
$800.00 K(-27.3%)
Aug 1994
$700.00 K(-63.2%)
$200.00 K(0.0%)
$1.10 M(-59.3%)
May 1994
-
$200.00 K(0.0%)
$2.70 M(+3.8%)
Feb 1994
-
$200.00 K(-60.0%)
$2.60 M(+8.3%)
Nov 1993
-
$500.00 K(-72.2%)
$2.40 M(+26.3%)
Aug 1993
$1.90 M
$1.80 M(+1700.0%)
$1.90 M(+1800.0%)
May 1993
-
$100.00 K
$100.00 K

FAQ

  • What is Anika Therapeutics annual SGA?
  • What is the all time high annual SGA for Anika Therapeutics?
  • What is Anika Therapeutics annual SGA year-on-year change?
  • What is Anika Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Anika Therapeutics?
  • What is Anika Therapeutics quarterly SGA year-on-year change?
  • What is Anika Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Anika Therapeutics?
  • What is Anika Therapeutics TTM SGA year-on-year change?

What is Anika Therapeutics annual SGA?

The current annual SGA of ANIK is $95.85 M

What is the all time high annual SGA for Anika Therapeutics?

Anika Therapeutics all-time high annual SGA is $95.85 M

What is Anika Therapeutics annual SGA year-on-year change?

Over the past year, ANIK annual SGA has changed by +$11.05 M (+13.04%)

What is Anika Therapeutics quarterly SGA?

The current quarterly SGA of ANIK is $19.11 M

What is the all time high quarterly SGA for Anika Therapeutics?

Anika Therapeutics all-time high quarterly SGA is $27.00 M

What is Anika Therapeutics quarterly SGA year-on-year change?

Over the past year, ANIK quarterly SGA has changed by $0.00 (0.00%)

What is Anika Therapeutics TTM SGA?

The current TTM SGA of ANIK is $468.57 M

What is the all time high TTM SGA for Anika Therapeutics?

Anika Therapeutics all-time high TTM SGA is $981.53 M

What is Anika Therapeutics TTM SGA year-on-year change?

Over the past year, ANIK TTM SGA has changed by +$387.79 M (+480.06%)